The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis

MLA

Samreen Khuwaja, et al. “The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis.” American Journal of Therapeutics, vol. 30, June 2022, pp. e288–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff9b1c878cd34c10263400c1e20abe7c&authtype=sso&custid=ns315887.

APA

Samreen Khuwaja, Nina Kohn, Shreya S. Sanghani, Sundas Khan, Arun Swaminath, & Keith Sultan. (2022). The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis. American Journal of Therapeutics, 30, e288–e291.

Chicago

Samreen Khuwaja, Nina Kohn, Shreya S. Sanghani, Sundas Khan, Arun Swaminath, and Keith Sultan. 2022. “The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis.” American Journal of Therapeutics 30 (June): e288–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........ff9b1c878cd34c10263400c1e20abe7c&authtype=sso&custid=ns315887.